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Abstract
Objective—To assess the relationship between estimated residential maternal exposure to
atrazine during pregnancy and risk for choanal atresia or stenosis in offspring.
Study Design—Data for 280 nonsyndromic cases and randomly selected, population-based
controls delivered during 1999 to 2008 were obtained from the Texas Birth Defects Registry.
County-level estimates of atrazine levels obtained from the United States Geological Survey were
assigned to cases and controls based on maternal county of residence at delivery. Unconditional
logistic regression was used to assess the relationship between maternal residential atrazine
exposure and risk for choanal atresia or stenosis in offspring.
Results—Compared to offspring of mothers with low levels of estimated residential atrazine
exposure, those with high levels had nearly a two-fold increase in risk for choanal atresia or
stenosis (adjusted odds ratio: 1.79, 95% confidence interval: 1.17–2.74). A significant linear trend
was also observed with increasing levels of atrazine exposure (adjusted P = 0.002).
Conclusions—A link between maternal exposure to endocrine disruptors, such as atrazine, and
choanal atresia risk is plausible based on previous findings. Our results further support this
hypothesis.
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Choanal atresia and stenosis are characterized by a complete blockage or narrowing,
respectively, of the opening between the posterior nasal cavity and the nasopharynx on the
left side, right side, or both.1 Choanal atresia and stenosis are the most common craniofacial
abnormalities of the nose and often require multiple corrective surgeries or can lead to life-
threatening airway obstruction.2, 3 In spite of its clinical significance, the etiology of choanal
atresia or stenosis in the absence of a chromosome abnormality or malformation syndrome
or sequence is not well understood in humans.4
Although there has been limited research evaluating the etiology of nonsyndromic choanal
atresia or stenosis, a few risk factors involved in endocrine function are suspected. For
example, multiple studies have demonstrated that in utero exposure to hyperthyroid
medications (i.e., methimazole and carbimazole, a carboxy derivative of methimazole) may
increase risk for choanal atresia.5–11 The exact mechanism of this suspected teratogenic
effect is unclear and a teratogenic role of the underlying hyperthyroidism has not been ruled
out. Other mechanisms suspected to increase choanal atresia risk include suppression of
retinoic acid and activation of fibroblast growth factor signaling pathways, both of which
regulate endocrine function.12, 13
Atrazine, the most widely used herbicide in the U.S., has been suggested to have teratogenic
effects for other birth defects and is considered to be a potent endocrine disruptor (i.e., a
chemical that interferes with the normal function of the endocrine system).14–18 However, to
our knowledge, atrazine exposure has not been evaluated with regards to choanal atresia or
stenosis specifically. Given the plausibility of a possible teratogenic effect of atrazine via
endocrine disruption, we evaluated the relationship between residential maternal exposure to
atrazine during pregnancy and risk for choanal atresia or stenosis in offspring in Texas
during 1999 to 2008.
METHODS
STUDY SUBJECTS
Analyses were conducted using data from the Texas Birth Defects Registry, which is an
ongoing, population-based registry maintained by the Texas Department of State Health
Services Birth Defects Epidemiology and Surveillance Branch (BDESB). The registry uses
state-wide active case surveillance at hospitals, birthing centers, and midwife facilities to
identify cases with birth defects, including live births, still births, and induced pregnancy
terminations. Potential cases are included in the registry when a structural birth defect or
chromosome abnormality is present and the mother resided in Texas at the time of delivery.
Medical records data for each case are abstracted and case diagnoses are reviewed and
classified using a six-digit code defined by the Centers for Disease Control and Prevention,
which is based on the British Pediatric Association Classification of Diseases and the
International Classification of Diseases, 9th Revision, Clinical Modification system (BPA
code).19 Registry data is also linked to reproductive and sociodemographic data (e.g.,
maternal address at delivery) from birth and fetal death certificates obtained from the Vital
Statistics Unit of the Texas Department of State Health Services. For the present analyses,
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corresponding vital records data were also obtained for potential controls, sampled from all
live births in Texas during the study period. These data included infant sex, delivery date,
and maternal race/ethnicity, birthplace, age, education, smoking (yes versus no), and history
of live births. The protocol for this study was approved by the Institutional Review Board
for the University of Texas Health Science Center at Houston.
Data for cases with documented postnatal diagnoses of choanal atresia or stenosis (BPA
code 748.000) delivered between January 1, 1999 and December 31, 2008 were included in
these analyses. Cases were not included when there was a choanal atresia or stenosis BPA
code but written comments indicating that the case did not have choanal atresia or stenosis
(N=64). To reduce the potential for etiologic heterogeneity among cases, all analyses were
restricted to nonsyndromic cases (i.e., those without possible diagnoses of chromosome
abnormalities or malformation syndromes or sequences). Further, analyses were repeated
among the subset of isolated cases (i.e., nonsyndromic cases without additional major
malformations). We also selected a random sample of controls without major malformations
delivered during the study period, using a ratio of ten controls to one case.
EXPOSURE ASSESSMENT
Annual estimates of atrazine levels were obtained for all counties in Texas from the United
States Geological Survey (USGS) for the period 1999–2007.20 Atrazine estimates from the
USGS model are based on agricultural crops (crop acreage and reported crops) that were
likely to have applications of atrazine. The method for developing these estimates has been
described elsewhere.20 Briefly, the USGS method uses AgroTrak survey data on pesticide
use and Census of Agriculture and National Agriculture Statistics Service data on harvested
crop acreages for all counties in the contiguous Unites States. To ensure that atrazine use
was accounted for in all geographic areas, atrazine crop application rates for Crop Reporting
Districts (CRDs) not surveyed were derived from adjacent CRDs that had been surveyed.
CRDs consist of multiple adjacent counties, which were grouped to represent similar
geography, climate, and cropping practices. For this assessment, data on the counties in
Texas were linked to maternal county of residence at delivery and year of delivery for cases
and controls. Because data for 2008 were not available, 2007 atrazine data were used for
2008 deliveries. For main analyses, atrazine exposure was categorized as low, medium,
medium-high, or high, defined by the distribution of atrazine levels in controls (i.e., based
on cutoffs below the 25th percentile, above the 25th and less than the 75th percentile, above
the 75th and less than the 90th percentile, and above the 90th percentile, respectively, as
used by Reynolds et al.21).
STATISTICAL ANALYSIS
The distribution of infant and maternal sociodemographic and reproductive characteristics
among cases and controls were by tabulated using counts and proportions and were
compared using a chi-square test. The distribution of overall atrazine levels in Texas was
also described by year. Further, for each county, mean atrazine levels across 1999–2007
were plotted.
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Frequencies of cases and controls were determined for each atrazine category (i.e., those
based on the 25th, 75th, and 90th percentile cutoffs in controls). In the main analyses,
unconditional logistic regression was used to assess the relationship between categories of
atrazine exposure and choanal atresia or stenosis. Using the category of low atrazine
exposure as a referent, crude odds ratios (ORs) were estimated for each atrazine exposure
level category. We also estimated ORs adjusted for the following potential confounders
(based on previous literature): season of conception, infant sex, birth year, and maternal
race/ethnicity, education, age, and smoking. Furthermore, adjusted p-values were estimated
to assess the potential for a linear trend across increasing categories of atrazine exposure.
We also assessed a linear trend using a continuous measurement of atrazine levels, based on
10,000 pound increments. To further limit potential heterogeneity, main analyses were
repeated among isolated cases. Analyses were conducted using SAS (version 9.2 copyright
2002–2008, SAS, Inc., Cary, NC) and STATA version 12 (StatCorp LP, College Station,
TX).
RESULTS
From 1999 to 2008, there were 372 cases in Texas with postnatal diagnoses of choanal
atresia or stenosis. Controls were randomly selected among all live births in Texas during
the study period at a ten to one control to case ratio (N=3720 controls). There were 28 cases
that had a chromosome abnormality and 64 cases that had a malformation syndrome or
sequence. The main analyses focused on the remaining 280 nonsyndromic cases. The
proportion of subjects missing maternal county of residence at delivery, and therefore
missing atrazine exposure level, was similar between cases and controls (0.4% and 0.5%,
respectively).
There were no significant differences in the distribution of characteristics (i.e., infant sex,
delivery year, or maternal race/ethnicity, birthplace, age at delivery, education, history of
previous live births, smoking, or season of conception) between cases and controls (Table I).
Further characteristics of a subset of these cases have been previously described in a
descriptive epidemiology study.4 The overall distribution of atrazine levels in Texas
between 1999 and 2007 are presented (Table II). The annual mean levels of atrazine
application in Texas ranged from a high of 19.5 pounds per square mile in 2000 to a low of
9.2 pounds per square mile in 2006. There was no obvious trend in estimated levels over
time.
Atrazine exposure was categorized based on the cutoffs in controls at the 25th, 75th, and
90th percentiles: 0–<1.40 pounds/square mile (low), 1.40–<15.03 pounds/square mile
(medium low), 15.03–<47.63 pounds/square mile (medium), and ≥47.63 pounds/square mile
(high). A map plotting atrazine exposure categories for each Texas county, based on mean
atrazine application over 1997–2007, is presented in Figure I. Based on these estimates;
levels of atrazine appeared to be both high and variable throughout the state.
Offspring of mothers with high levels of estimated residential atrazine exposure had a
significantly increased risk of choanal atresia or stenosis compared to those with low
exposure levels (OR: 1.65, 95% CI: 1.10–2.48) (Table III). A similar association was
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observed after adjustment for season of conception, infant sex, birth year, and maternal race/
ethnicity, education, age, and smoking (adjusted OR: 1.79, 95% CI: 1.17–2.74). The
unadjusted and adjusted magnitudes of association across the categories of exposure were
consistent with a dose-response over increasing levels of atrazine exposure. A significant
linear trend was also observed with increasing category of atrazine exposure (adjusted
P=0.002). Main analyses were also repeated using a continuous measure of atrazine
exposure (i.e., based on 100 pound per square mile increments). A significant linear increase
was observed (OR: 1.40, 95% CI: 1.04–1.89; adjusted OR: 1.49, 95% CI: 1.09–2.04).
To further limit heterogeneity, analyses were repeated among isolated cases (N=147). The
results from these analyses were similar to the main results (data not shown).
DISCUSSION
We found a significant association between estimated maternal residential exposure to
atrazine and risk for nonsyndromic or isolated choanal atresia or stenosis in offspring.
Specifically, the prevalence of choanal atresia or stenosis was highest among offspring of
women who lived in counties with the highest estimated levels of atrazine use. Our results
suggest a monotonic dose-response relationship, whereby living in counties with increasing
atrazine application is associated with increasing risk of having a child with choanal atresia
or stenosis.
As there are no large-scale population-based measurements of personal atrazine exposure,
our exposure assessment strategy was based on county-level estimates of atrazine
application provided by the USGS, and therefore, our results should be interpreted
cautiously. However, living in areas with high levels of atrazine application (e.g., proximity
to agricultural fields) appears to correlate with personal exposure.14, 15 For instance, families
living in farm households have higher levels of urine atrazine metabolites compared to
families living in non-farm households.22
Based on research in animal models, the primary target of atrazine toxicity is the female
reproductive system; therefore, there is growing interest in the association between atrazine
exposure in humans and birth defects.15 Although the relationship between maternal atrazine
exposure and risk for choanal atresia or stenosis has not been previously evaluated, our
findings are consistent with previous reports of associations between atrazine exposure and
adverse pregnancy outcomes and other birth defects, such as gastroschisis, spina bifida, cleft
lip, congenital heart defects, limb reduction defects and urogenital defects.15–18
Additionally, as atrazine is a suspected endocrine disruptor in humans (including disruption
of thyroid hormone), and there is evidence that choanal atresia risk is associated with in
utero exposure to hyperthyroid medications, it is plausible that choanal atresia may be an
atrazine-susceptible phenotype.5–11 While the pathways involved in atrazine-induced
tertatogenesis have not been elucidated (particularly for choanal atresia), there are three
potential mechanisms that warrant further exploration. First, it is possible that atrazine may
interfere with maternal thyroid hormone levels during pregnancy, thereby increasing the risk
of choanal atresia. Second, atrazine exposure (and exposure to other endocrine disruptors)
Agopian et al. Page 5






















may actually lead to maternal hyperthyroidism prior to pregnancy, which may lead to this
effect. Third, previous studies have shown that risk for choanal atresia or stenosis increases
in mice with suppression of retinoic acid synthesis (i.e., vitamin A deficiency) or activation
of fibroblast growth factor signaling pathways.12, 13 Although the relationships between the
thyroid hormone, retinoic acid, and fibroblast growth factor signaling pathways during
development are not fully understood, it has been suggested that retinoic acid regulates
thyroid function and that thyroid hormones regulate fibroblast growth factor receptor
signaling.23, 24 While it is unclear if atrazine might be involved in retinoic acid synthesis or
fibroblast growth factor signaling, it is possible that precursors or derivatives of atrazine
might be involved.
This study must be considered in the light of certain limitations. Given that the critical
period for exposure for choanal atresia is early in pregnancy,25 residential atrazine exposure
based on maternal residence at delivery may not have accurately represented residential
atrazine exposure during the critical period for all subjects. However, we have previously
shown that residential mobility from one county to another between conception and delivery
is infrequent in Texas (i.e., ≤6%) and is expected to occur at similar proportions between
cases and controls.26 As stated, we used a county-based estimate of atrazine exposure in the
present study, which may not adequately account for variability of exposure within counties
or within years; however, there are no large-scale population-based measures of personal
exposure, which could be used in order to evaluate this relatively rare phenotype. Thus, the
present study is an important first step in determining what associations may be present.
Although we adjusted for several potential confounders, we cannot rule out the possibility of
confounding by unmeasured variables. Future research is needed to confirm our findings,
using other exposure assessment methodologies, including biomarkers of exposure. We
were also limited in our case sample size, due to the rarity of choanal atresia or stenosis.
In spite of these limitations, the present study had several strengths, including use of a
sample that utilized active surveillance to identify cases. The sample also included cases that
were still births and elective pregnancy terminations, which reduced the potential for
selection bias. Although choanal atresia or stenosis is a rare condition, the Texas Birth
Defects Registry represents one of largest population-based birth defects registries in the
world, and our sample contained more cases with nonsyndromic choanal atresia or stenosis
than most previous studies. Additionally, to reduce heterogeneity, we restricted our case
definition to nonsyndromic cases and also considered isolated cases separately.
In summary, we report the first identified association between maternal atrazine exposure
and risk for choanal atresia or stenosis. Moreover, our findings, in conjunction with previous
studies, suggest an important role of maternal endocrine disruption in risk for choanal atresia
or stenosis. If confirmed, future research evaluating the many other factors that influence
endocrine function may shed further light on the etiology of choanal atresia or stenosis.
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Distribution of mean atrazine levels in Texas by county over 1999–2007
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Table I
Characteristics of controls and nonsyndromic cases with choanal atresia in Texas, 1999–2008
Characteristic Cases (N=280) Controls (N=3720) P
Infant Sex
 Female 138 (49.5%) 1813 (48.7%) 0.68
 Male 141 (50.5%) 1907 (51.3%)
Delivery year
 1999 28 (10.0%) 363 (9.8 %) 0.65
 2000 29 (10.4%) 364 (9.8 %)
 2001 32 (11.4%) 353 (9.5%)
 2002 25 (8.9%) 387 (10.4%)
 2003 25 (8.9%) 354 (9.5%)
 2004 23 (8.2%) 406 (10.9%)
 2005 29 (10.4%) 365 (9.8%)
 2006 36 (12.9%) 364 (9.8%)
 2007 22 (7.9%) 368 (9.9%)
 2008 31 (11.1%) 396 (10.7%)
Maternal race/ethnicity
 Non-Hispanic white 110 (39.4%) 1310 (35.2%) 0.41
 Non-Hispanic black 30 (10.8%) 447 (12.0%)
 Hispanic 133 (47.7%) 1831 (49.3%)
 Other 6 (2.2%) 130 (3.5%)
Maternal birthplace
 United States 207 (73.9%) 2638 (70.9%) 0.21
 Outside United States 73 (26.1%) 1082 (29.1%)
Maternal age
 <20 33 (11.8%) 562 (15.1%) 0.48
 20–24 77 (27.5%) 989 (26.6%)
 25–29 79 (28.2%) 1034 (27.8%)
 30–34 56 (20.0%) 755 (20.3%)
 35–39 28 (10.0%) 320 (8.6%)
 ≥40 7 (2.5%) 60 (1.6%)
Maternal education
 < High school 92 (33.5%) 1167 (31.8%) 0.90
 High school 79 (28.7%) 1069 (29.1%)
 > High school 104 (37.8%) 1439 (37.2%)
Previous live births
 No 102 (37.5%) 1388 (38.4%) 0.98
 Yes 170 (62.5%) 2231 (61.7%)
Maternal smoking
 No 259 (92.8%) 3499 (94.4%) 0.25
 Yes 20 (7.2%) 209 (5.6%)
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Characteristic Cases (N=280) Controls (N=3720) P
Season of conception
 Spring 73 (26.2%) 920 (24.8%) 0.26
 Summer 74 (26.5%) 858 (23.1%)
 Fall 72 (25.8%) 939 (25.3%)
 Winter 60 (21.5%) 992 (26.8%)
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Table II
Distribution of atrazine levels (pounds per square mile) in Texas by year, 1999–2007
Year Mean Median Minimum Maximum
1999 14.71 3.83 0.00009 194.6
2000 19.53 4.83 0.00009 223.8
2001 15.18 3.04 0.0002 211.3
2002 14.80 2.16 0.0002 235.5
2003 15.73 3.58 0.001 161.1
2004 13.82 2.28 0.0004 177.6
2005 11.89 2.47 0.0001 211.4
2006 9.24 2.27 0.0004 115.9
2007 15.68 3.03 0.0006 352.5
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